Skyline Therapeutics, an innovation-driven clinical-stage gene therapy company focused on developing unique and novel solutions for rare and severe diseases, today announced a late-breaking ...

The two companies claim AGN-151587 (EDIT-101) for Leber congenital amaurosis ... is a technology that can edit DNA at precise locations in the human genome, allowing genes to be permanently ...

At MIT, one genome researcher is testing a different approach. Bin Zhang, associate professor of chemistry and the leader of ...

The genome structure—how genes are organized within DNA sequences in an organism—is fundamental to the processes and ...

Life depends on genes being switched on and off at exactly the right time. Even the simplest living organisms do this, but ...

Despite rapid advances in genome and exome sequencing, many individuals with rare diseases remain undiagnosed. In a ...

A recent study marks the first reported instance of generative AI designing synthetic molecules that can successfully control gene expression in healthy mammalian cells. As a proof-of-concept, the ...

Comb jellies "could repurpose [their] genetic toolkit in different ways like a Swiss knife," said the researchers.

The saola’s newly sequenced genome offers hope for one of Earth’s rarest mammals.

Othram, a Texas-based forensic laboratory that specializes in genome sequencing to help solve ... in February 1993 turned out to be a partial human skull that he handed over to the nearby Fortuna ...

CRISPR-Cas9 genome editing exploits the CRISPR-Cas system ... amplification-free detection of pathogens from human serum. Here, the authors describe a highly efficient gene drive targeting the ...